Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blocks for Hip Surgery Analgesia
Key facts
- Where
- Cairo, EgyptSee the site
Where in Egypt
- Ain Shams UniversityCairo, EgyptContact: Merna H Hilal, MB BCh, MScNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Ain Shams University
- Trial code
- NCT07531030
- Record updated
- 22 April 2026
- Original description
This study aims to investigate the efficacy of adding a Posterior Pericapsular Deep gluteal block to two other standard nerve blocks-the Pericapsular Nerve Group block and the Lateral Femoral Cutaneous Nerve block-for patients undergoing orthopedic hip surgery. While standard blocks target the front of the hip, many patients still feel pain in the back (posterior) of the joint. Researchers will compare two groups of patients to see if this triple-block combination provides better pain relief and reduces the need for rescue opioid medications in the 24 hours following surgery.Read full original descriptionShow less
Efficacy of Combining Ultrasound-guided Posterior Pericapsular Deep Gluteal Block to Both Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blocks for Postoperative Analgesia in Orthopedic Hip Surgeries
This study aims to investigate the efficacy of adding a Posterior Pericapsular Deep gluteal block to two other standard nerve blocks-the Pericapsular Nerve Group block and the Lateral Femoral Cutaneous Nerve block-for patients undergoing orthopedic hip surgery. While standard blocks target the front of the hip, many patients still feel pain in the back (posterior) of the joint. Researchers will compare two groups of patients to see if this triple-block combination provides better pain relief and reduces the need for rescue opioid medications in the 24 hours following surgery.
Inclusion: Age greater than or equal to 18 years; Both genders included; American Society of Anesthesiologists (ASA) physical status classification I-III; Undergoing elective orthopedic hip surgery; Provision of written informed consent.
Exclusion: Allergy to any of the drugs used in the study; Local skin infection at the injection site; Coagulation disorder; History of cardiac arrhythmia, seizures, or increased intracranial tension; Alcohol or drug abuse, or psychiatric disease; History of chronic pain; Patient refusal of procedure or participation; American Society of Anesthesiologists (ASA) physical status classification IV.